{"id":"gom-ns","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4303572","moleculeType":"Small molecule","molecularWeight":"427.18"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Without access to detailed clinical trial data or published mechanism information, the precise molecular target and pharmacological action of GOM-NS cannot be reliably determined. Phase 3 status indicates it has progressed beyond early-stage testing, but the mechanism remains proprietary or undisclosed in available sources.","oneSentence":"GOM-NS is an investigational drug in phase 3 development by Glenmark Specialty S.A., but its specific mechanism of action is not publicly disclosed.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:14:09.967Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT02870205","phase":"PHASE3","title":"Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2016-08","conditions":"Seasonal Allergic Rhinitis (SAR)","enrollment":1176}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"GOM-NS","genericName":"GOM-NS","companyName":"Glenmark Specialty S.A.","companyId":"glenmark-specialty-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}